Alprostadil (Alprostapint/Pridax)
Erectile Dysfunction, Peripheral Vascular Disease
ApprovedActive
Key Facts
Indication
Erectile Dysfunction, Peripheral Vascular Disease
Phase
Approved
Status
Active
Company
About Gebro Pharma
Gebro Pharma is a century-old, privately held Austrian pharmaceutical company with a strong emphasis on maintaining its independence and family ownership. Its core business is the development, licensing, and global commercialization of a portfolio of small molecule therapeutics, many of which are already approved and marketed. The company leverages a decentralized operational structure with key subsidiaries in Europe to manage risks and drive international growth, particularly in Latin America and other emerging markets.
View full company profile